Literature DB >> 11943878

Integration of signals from receptor tyrosine kinases and g protein-coupled receptors.

Vicki L Lowes1, Nancy Y Ip, Yung H Wong.   

Abstract

Activation of G protein-coupled receptors (GPCRs) leads to stimulation of classical G protein signaling pathways. In addition, GPCRs can activate the mitogen-activated protein kinases (MAPKs) such as the extracellular signal-regulated kinases, c-Jun NH(2)-terminal kinases (JNKs), and p38 MAPKs, and thereby influence cell proliferation, cell differentiation and mitogenesis. Cross talk between GPCRs and receptor tyrosine kinases (RTKs) is an incredibly complex process, and the exact signaling molecules involved are largely dependent on the cell type and the type of receptor that is activated. In this review we investigate recent advances that have been made in understanding the mechanisms of cross talk between GPCRs and RTKs, with a focus on GPCR-mediated activation of the Ras/MAPK pathway, GPCR-induced transactivation of RTKs, GPCR-mediated activation of JNK, and p38 MAPK, integration of signals by RhoGTPases, and activation of G protein signaling pathways by RTKs. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11943878     DOI: 10.1159/000057317

Source DB:  PubMed          Journal:  Neurosignals        ISSN: 1424-862X


  36 in total

Review 1.  Multiple serotonergic mechanisms contributing to sensitization in aplysia: evidence of diverse serotonin receptor subtypes.

Authors:  Demian Barbas; Luc DesGroseillers; Vincent F Castellucci; Thomas J Carew; Stéphane Marinesco
Journal:  Learn Mem       Date:  2003 Sep-Oct       Impact factor: 2.460

2.  Epidermal growth factor differentially augments G(i)-mediated stimulation of c-Jun N-terminal kinase activity.

Authors:  Anthony S L Chan; Yung H Wong
Journal:  Br J Pharmacol       Date:  2004-06-01       Impact factor: 8.739

Review 3.  Intracellular calcium signals and control of cell proliferation: how many mechanisms?

Authors:  L Munaron; S Antoniotti; D Lovisolo
Journal:  J Cell Mol Med       Date:  2004 Apr-Jun       Impact factor: 5.310

Review 4.  Heterotrimeric G protein signaling outside the realm of seven transmembrane domain receptors.

Authors:  Caroline Marty; Richard D Ye
Journal:  Mol Pharmacol       Date:  2010-04-19       Impact factor: 4.436

5.  Vitamin E down-modulates mitogen-activated protein kinases, nuclear factor-kappaB and inflammatory responses in lung epithelial cells.

Authors:  B Ekstrand-Hammarström; C Osterlund; B Lilliehöök; A Bucht
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

6.  Paeoniflorin ameliorates ischemic neuronal damage in vitro via adenosine A1 receptor-mediated transactivation of epidermal growth factor receptor.

Authors:  Min Zhong; Wan-ling Song; Ye-chun Xu; Yang Ye; Lin-yin Feng
Journal:  Acta Pharmacol Sin       Date:  2015-02-09       Impact factor: 6.150

7.  Chemerin receptor blockade improves vascular function in diabetic obese mice via redox-sensitive and Akt-dependent pathways.

Authors:  Karla Bianca Neves; Aurelie Nguyen Dinh Cat; Rheure Alves-Lopes; Katie Yates Harvey; Rafael Menezes da Costa; Nubia Souza Lobato; Augusto Cesar Montezano; Ana Maria de Oliveira; Rhian M Touyz; Rita C Tostes
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-09-14       Impact factor: 4.733

8.  Importance of ERK activation in behavioral and biochemical effects induced by MDMA in mice.

Authors:  Julie Salzmann; Cynthia Marie-Claire; Stephanie Le Guen; Bernard P Roques; Florence Noble
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

9.  Quantitative measurement of estrogen-induced ERK 1 and 2 activation via multiple membrane-initiated signaling pathways.

Authors:  Nataliya N Bulayeva; Bahiru Gametchu; Cheryl S Watson
Journal:  Steroids       Date:  2004-03       Impact factor: 2.668

Review 10.  Signal transduction via cannabinoid receptors.

Authors:  George D Dalton; Caroline E Bass; C G Van Horn; Allyn C Howlett
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-12       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.